Incannex Healthcare Inc. (IXHL)
IXHL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.91
+0.34% on the day
Market cap
$36.5M
Nano cap
Revenue · 2024
$12K
No prior year to compare
Net income · 2024
-$18.5M
-153825.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | IXHL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Australia |
| IPO year | Not reported by the screener |
| SEC CIK | 0001873875 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $12K |
| Net income | -$18.5M |
| Operating income | -$30.0M |
| Net margin | -153825.0% |
| Operating margin | -250341.7% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $2.1M |
| Total assets | $11.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3042.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-03-12 |
| Latest annual report | 10-K | 2026-09-25 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-05-15 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-09 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2025-12-18 |
Source: SEC EDGAR submissions feed, 263 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LITS | Lite Strategy Inc. | $1.21 | -0.82% | $36.8M |
| NSRX | Nasus Pharma Ltd. | $3.16 | -4.82% | $37.0M |
| FLNA | Filana Therapeutics Inc. | $0.7434 | -3.39% | $35.9M |
| VERU | Veru Inc. | $2.19 | -8.94% | $37.3M |
| EDSA | Edesa Biotech Inc. Common Shares | $2.85 | -3.23% | $38.4M |
| CRVO | CervoMed Inc. | $2.27 | -9.56% | $34.3M |
| IBO | Impact BioMedical Inc. | $3.98 | -1.24% | $34.0M |
| NNVC | NanoViricides Inc. | $1.32 | +3.13% | $33.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier